Artículos de revistas
Withdrawal Of Maintenance Therapy For Cytomegalovirus Retinitis In Aids Patients Exhibiting Immunological Response To Haart
Registro en:
Revista Do Instituto De Medicina Tropical De Sao Paulo. , v. 49, n. 4, p. 215 - 219, 2007.
364665
2-s2.0-34548627902
Autor
Waib L.F.
Bonon S.H.A.
Salles A.C.
Benard G.
De Oliveira A.C.P.
Pannuti C.S.
Pedro R.D.J.
Costa S.C.B.
Institución
Resumen
Background: Before the introduction of highly active antiretroviral therapy (HAART), CMV retinitis was a common complication in patients with advanced HIV disease and the therapy was well established; it consisted of an induction phase to control the infection with ganciclovir, followed by a lifelong maintenance phase to avoid or delay relapses. Methods: To determine the safety of CMV maintenance therapy withdrawal in patients with immune recovery after HAART, 35 patients with treated CMV retinitis, on maintenance therapy, with CD4+ cell count greater than 100 cells/mm3 for at least three months, but almost all patients presented these values for more than six months and viral load < 30000 copies/mL, were prospectively evaluated for the recurrence of CMV disease. Maintenance therapy was withdrawal at inclusion, and patients were monitored for at least 48 weeks by clinical and ophthalmologic evaluations, and by determination of CMV viremia markers (antigenemia-pp65), CD4+/CD8+ counts and plasma HIV RNA levels. Lymphoproliferative assays were performed on 26/35 patients. Results: From 35 patients included, only one had confirmed reactivation of CMV retinitis, at day 120 of follow-up. No patient returned positive antigenemia tests. No correlation between lymphoproliferative assays and CD4+ counts was observed. Conclusion: CMV retinitis maintenance therapy discontinuation is safe for those patients with quantitative immune recovery after HAART. 49 4 215 219 ACTG, Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group. New Engl. J. Med, 326: 213-220, 1992BERENGUER, J., GONZALEZ, J., PULIDO, J., Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy (2002) Clin. infect. Dis, 34, pp. 394-397 BONON, S.H., MENONI, S.M.F., ROSSI, C.L., Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients (2005) J. Infect, 50, pp. 130-137 CASSOUX, N., BODAGHI, B., KATLAMA, C., LEHOANG, P., CMV retinitis in the era of HAART (1999) Ocul. Immunol. Inflamm, 7, pp. 231-235 CURI, A.L., MURALHA, A., MURALHA, L., PAVESIO, C., Suspension of anticytomegalovirus maintenance therapy following immune recovery due to highly active antiretroviral therapy (2001) Brit. J. Ophthal, 85, pp. 471-473 DEAYTON, J. WILSON, J.R. SABIN, P. et al. - Recovery of antibody responses to Cytomegalovirus (CMV) Glycoprotein B (gB) following Highly Active Antiretroviral Therapy (HAART). In: CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS, 6., Chicago, 1999. p. 153DEAYTON, J.R., WILSON, P., SABIN, C., Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy (2000) Aids, 14, pp. 1163-1670 DEGREZIA, M.G., ROBINSON, M., Ophthalmic manifestations of HIV: An update (2001) J. Ass. Nurses AIDS Care, 12, pp. 22-32 FRANCISCI, D., TOSTI, A., PREZIOSI, R., Role of antigenemia assay in the early diagnosis and prediction of human cytomegalovirus organ involvement in AIDS patients (1995) Europ. J. clin. Microbiol. infect. Dis, 14, pp. 498-503 GALLANT, J.E., MOORE, R.D., RICHMAN, D.D., KERULY, J., CHAISSON, R.E., Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group (1992) J. infect. Dis, 166, pp. 1223-1227 GERNA, G., PICCININI, G., GENINI, E., Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART (2001) J. acquir. immune Defic. Syndr, 28, pp. 320-331 GOLDBERG, D.E., SMITHEN, L.M., ANGELILLI, A., FREEMAN, W.R., HIV-associated retinopathy in the HAART era (2005) Retina, 25, pp. 633-649 HALWACHS, G., ZACH, G., POGGLITSCH, H., A rapid immunocytochemical assay for CMV detection in peripheral blood of organ-transplanted patients in clinical practice (1993) Transplantation, 56, pp. 338-342 HENDERSON, H.W., MITCHELL, S.M., Treatment of immune recovery vitritis with local steroids (1999) Brit. J. Ophthal, 83, pp. 540-545 HOOVER, D.R., PENG, Y., SAAH, A., Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression (1996) Arch. Ophthal, 114, pp. 821-827 JABS, D.A., VAN NATTA, M.L., KEMPEN, M.L., Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy (2002) Amer. J. Ophthal, 133, pp. 48-61 JACOBSON, M.A., Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (1997) New Engl. J. Med, 337, pp. 105-114 JACOBSON, M.A., ZEGANS, M.A., PAVAN, M., Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy (1997) Lancet, 349, pp. 1443-1445 JOUAN, M. SAVES, M. TUBIANA, M. et al. - A prospective multicentre study to evaluate the discontinuation of maintenance therapy for CMV Retinitis in HIV-patients receiving HAART. In: CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS, 6., Chicago, 1999JOUAN, M., SAVES, M., TUBIANA, M., Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy (2001) Aids, 15, pp. 23-31 KARAVELLAS, M.P., PLUMMER, M.P., MACDONALD, D.J., Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy (1999) J. infect. Dis, 179, pp. 697-700 KEANE, N.M., PRICE, P., STONE, S.F., Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy (2000) AIDS Res. hum. Retroviruses, 16, pp. 1991-1996 LI, T.S., TUBIANA, R., KATLAMA, C., Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease (1998) Lancet, 351, pp. 1682-1686 MACDONALD, J.C., KARAVELLAS, M.P., TORRIANI, F.J., Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis (2000) Ophthalmology, 107, pp. 877-881 MACDONALD, J.C., TORRIANI, F.J., MORSE, L.S., Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy (1998) J. infect. Dis, 177, pp. 1182-1187 MARGOLIS, T.P., Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis (2000) Surv. Ophthal, 44, p. 455 MITCHELL, S.M., MEMBREY, W.L., YOULE, M.S., Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: A 2-year prospective study (1999) Brit. J. Ophthal, 83, pp. 652-655 PANNUTI, C.S., KALLAS, E.G., MUCCIOLI, C., Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis (1996) Amer. J. Ophthal, 122, pp. 847-852 PICCININI, G., COMOLLI, G., GENINI, G., Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patients (2001) Clin. diagn. Lab. Immunol, 8, pp. 1225-1230 POSTELMANS, L., GERARD, M., SOMMEREIJNS, B., CASPERS-VELU, L., Discontinuation of maintenance therapy for CMV retinitis in AIDS patients on highly active antiretroviral therapy (1999) Ocul. Immunol. Inflamm, 7, pp. 199-203 POWDERLY, W.G., LANDAY, A., LEDERMAN, M.M., Recovery of the immune system with antiretroviral therapy: The end of opportunism? (1998) J. Amer. med. Ass, 280, pp. 72-77 RUHSWURM, I., RIES, I., KREPLER, E., Control of cytomegalovirus retinitis after combination antiretroviral therapy (1999) Acta Ophthal. Scand, 77, pp. 471-473 SALMON-CERON, D., Cytomegalovirus infection: The point in 2001 (2001) HIV Med, 2, pp. 255-259 SMITH, M.A., BRENNESSEL, D.J., Cytomegalovirus (1994) Infect. Dis. Clin. N. Amer, 8, pp. 427-438 SODERBERG-NAUCLER, C., NELSON, J.Y., Human cytomegalovirus latency and reactivation - a delicate balance between the virus and its host's immune system (1999) Intervirology, 42, pp. 314-321 SORIANO, V., DONA, C., RODRIGUEZ-ROSADO, R., BARREIRO, P., GONZALEZ-LAHOZ, J., Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy (2000) Aids, 14, pp. 383-386 STEININGER, C., PUCHHAMMER-STOCKL, E., POPOW-KRAUPP, T., Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART) (2006) J. clin. Virol, 37, pp. 1-9 TAY-KEARNEY, M.L., JABS, D.A., Ophthalmic complications of HIV infection (1996) Med. Clin. N. Amer, 80, pp. 1471-1492 TUFAIL, A., MOE, A.A., MILLER, M.J., Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome (1999) Ophthalmology, 106, pp. 133-141 TURAL, C. ROMEU, C. SIRERA, J. et al. - A 24 month follow-up of cytomegalovirus retinitis without secondary prophylaxis following highly active antiretroviral therapy. In: CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS, 6., Chicago, 1999. p. 153 (Abstract no. 455)TURAL, C., ROMEU, J., SIRERA, J., Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients (1998) J. infect. Dis, 177, pp. 1080-1083 VAN DER BIJ, W., VAN SON, W.J., VAN DER BERG, A.P., Cytomegalovirus (CMV) antigenemia: Rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients (1989) Transplant. Proc, 21, pp. 2061-2064 VRABEC, T.R., BALDASSANO, V.F., WHITCUP, S.M., Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts (1998) Ophthalmology, 105, pp. 1259-1264 WEINBERG, A. WOHL, D.A. BARRETT, R.J. & VAN DER HORST, C. -Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J. infect. Dis., 184: 707-712, 2001WHITCUP, S.M., FORTIN, E., LINDBLAD, A.S., Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis (1999) J. Amer. med. Ass, 282, pp. 1633-1637 WOHL, D.A., KENDALL, M.A., OWENS, S., The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy (2005) HIV clin. Trials, 6, pp. 136-146